# Madrigal Pharmaceuticals, Inc.: Form 8-K, filed May 7, 2024

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: 8-K
- Filed: 2024-05-07
- Accepted by EDGAR: May 7, 2024, 16:36 ET
- Period: 2024-05-07
- Accession: 0001193125-24-133196
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000119312524133196/d815387d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000119312524133196/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000119312524133196/d815387d8k.htm

Filed May 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-133196. Last ingested by Listed: Nov 6, 2026, 18:49 ET. No prices; not investment advice.